Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0860-1, published online 11 May 2020.
In the version of this article initially published, three accession numbers (EGAS00001004229, EGAS00001004386 and EGAS00001004387) were missing from the Data Availability Statement in the HTML. The correct statement is as follows: “Raw data analyzed in this study have been submitted to the European Genome-Phenome Archive with accession numbers EGAS00001004008, EGAS00001004229, EGAS00001004230, EGAS00001004386 and EGAS00001004387.” The error has been corrected in the HTML version of the article. Also, the original Reporting Summary file has been replaced with a revised file that includes these accession numbers.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yuen, K.C., Liu, LF., Gupta, V. et al. Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med 27, 560 (2021). https://doi.org/10.1038/s41591-021-01246-4
Published:
Issue date:
DOI: https://doi.org/10.1038/s41591-021-01246-4
This article is cited by
-
A novel model for predicting immunotherapy response and prognosis in NSCLC patients
Cancer Cell International (2025)
-
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Journal of Gastroenterology (2025)
-
Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial
Signal Transduction and Targeted Therapy (2024)
-
Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment
Medical Oncology (2023)
